Enhertu
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Enhertu in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Enhertu.
13
2030 Global forecast Ranking
Recent articles on PMLiVE featuring Enhertu
Around one in five breast cancer cases are HER2-positive
This year marks the congress’s 50th anniversary, with the theme: Many journeys. One global community
Around one in three patients with early-stage breast cancer are considered high risk
Up to 20% of patients with metastatic breast cancer are affected by HER2-positive disease
Approximately 557,000 people are diagnosed with breast cancer every year in Europe
More than 300,000 cases of breast cancer are diagnosed in the US every year
The company will use Alteogen’s hybrozyme technology to advance the formulation
The rare form of non-Hodgkin lymphoma is estimated to affect more than 27,500 people globally
More than two million cases of breast cancer were diagnosed globally in 2022
The ADC has been authorised to treat adults with unresectable or metastatic HER2-positive tumours
Breast cancer is the most common form of cancer in the UK, accounting for over 55,000 cases every year
Non-small cell lung cancer accounts for approximately 85% of all lung cancer cases
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology